HuagongsheHuagongshe Chemistry Print Report · For research reference only
(2S)-1-(1,3-benzoxazol-2-yl)-2-piperidinecarboxylic acid → (2S)-1-(1,3-benzoxazol-2-yl)-N2-[2-(3,5-dimethylmorpholino)ethyl]-2-piperidinecarboxamide
Participants
| Role | Name | HCID | Charge |
|---|---|---|---|
| Reactant | (2S)-1-(1,3-benzoxazol-2-yl)-2-piperidinecarboxylic acid | HCID 12050655 | — |
| Reactant | 2-(3,5-Dimethylmorpholino)ethylamine | HCID 12096138 | — |
| Product | (2S)-1-(1,3-benzoxazol-2-yl)-N2-[2-(3,5-dimethylmorpholino)ethyl]-2-piperidinecarboxamide | HCID 9843166 | — |
Reaction Steps
The title compound was prepared by a similar method to Example 1 from (2S)-1-(1,3-benzoxazol-2-yl)-2-piperidinecarboxylic acid [see Preparation 3] and 2-(3,5-dimethylmorpholino)ethylamine [see Preparation 12]. The crude product was purified by column chromatography on silica gel eluting with a solvent gradient of 100:0 changing to 95:5, by volume dichloromethane:methanol to afford (2S)-1-(1,3-benzoxazol-2-yl)-N2 -[2-(3,5-dimethylmorpholino)ethyl]-2-piperidinecarboxamide as a solid.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| Patent number | US06166011 |
| Source dataset | uspto-grants-2000_12 |
| ORD ID | ord-6e04c36176d540d58deb19feac561936 |
| Source note | uspto-grants-2000_12 |